Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Unusually high prostate-specific antigen bounce after prostate brachytherapy: Searching for etiologic factors.

Chira C, Taussky D, Gruszczynski N, Meissner A, Larrivée S, Carrier JF, Donath D, Delouya G.

Brachytherapy. 2013 Nov-Dec;12(6):603-7. doi: 10.1016/j.brachy.2013.05.005.

PMID:
23891340
2.

Relationship between prostate-specific antigen bounce body fat distribution and body mass index in permanent seed brachytherapy for prostate cancer.

Delouya G, Taussky D, Ji CR, Sylvestre MP, Donath D.

Brachytherapy. 2012 May-Jun;11(3):214-8. doi: 10.1016/j.brachy.2011.05.009.

PMID:
21700507
3.

Analysis of prostate-specific antigen bounce after I(125) permanent seed implant for localised prostate cancer.

Mitchell DM, Swindell R, Elliott T, Wylie JP, Taylor CM, Logue JP.

Radiother Oncol. 2008 Jul;88(1):102-7. doi: 10.1016/j.radonc.2008.04.004.

PMID:
18453022
4.

PSA bounce predicts early success in patients with permanent iodine-125 prostate implant.

Patel C, Elshaikh MA, Angermeier K, Ulchaker J, Klein EA, Chehade N, Wilkinson DA, Reddy CA, Ciezki JP.

Urology. 2004 Jan;63(1):110-3.

PMID:
14751360
5.

Evaluating the Phoenix definition of biochemical failure after (125)I prostate brachytherapy: Can PSA kinetics distinguish PSA failures from PSA bounces?

Thompson A, Keyes M, Pickles T, Palma D, Moravan V, Spadinger I, Lapointe V, Morris WJ.

Int J Radiat Oncol Biol Phys. 2010 Oct 1;78(2):415-21. doi: 10.1016/j.ijrobp.2009.07.1724.

PMID:
20133083
6.

Prediction of PSA bounce after permanent prostate brachytherapy for localized prostate cancer.

Kanai K, Nakashima J, Sugawara A, Shigematsu N, Nagata H, Kikuchi E, Miyajima A, Nakagawa K, Kubo A, Oya M.

Int J Clin Oncol. 2009 Dec;14(6):502-6. doi: 10.1007/s10147-009-0909-0.

PMID:
19967485
7.

Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age.

Critz FA, Williams WH, Levinson AK, Benton JB, Schnell FJ, Holladay CT, Shrake PD.

J Urol. 2003 Nov;170(5):1864-7.

PMID:
14532794
8.

Permanent 125I-seed prostate brachytherapy: early prostate specific antigen value as a predictor of PSA bounce occurrence.

Mazeron R, Bajard A, Montbarbon X, Gassa F, Malet C, Rocher F, Clippe S, Bringeon G, Desmettre O, Pommier P.

Radiat Oncol. 2012 Mar 26;7:46. doi: 10.1186/1748-717X-7-46.

9.

Prostate-specific antigen spikes after permanent prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL.

Int J Radiat Oncol Biol Phys. 2002 Oct 1;54(2):450-6.

PMID:
12243821
10.

[PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure].

Toledano A, Chauveinc L, Flam T, Thiounn N, Solignac S, Timbert M, Rosenwald JC, Cosset JM.

Cancer Radiother. 2007 May;11(3):105-10. French.

PMID:
17158082
11.

PSA kinetics and PSA bounce following permanent seed prostate brachytherapy.

Crook J, Gillan C, Yeung I, Austen L, McLean M, Lockwood G.

Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):426-33.

PMID:
17869662
12.

Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality.

Kollmeier MA, Stock RG, Stone N.

Int J Radiat Oncol Biol Phys. 2003 Nov 1;57(3):645-53.

PMID:
14529768
13.

Risk factors for PSA bounce following radiotherapy: outcomes from a multi-modal therapy analysis.

Waters A, Delouya G, Donath D, Lambert C, Larrivée S, Zorn KC, Taussky D.

Can J Urol. 2014 Dec;21(6):7548-53.

PMID:
25483763
14.

Relationship between sexual function and prostate-specific antigen bounce after iodine-125 permanent implant brachytherapy for localized prostate cancer.

Nishihara K, Nakiri M, Chikui K, Suekane S, Matsuoka K, Hattori C, Ogo E, Abe T, Matsumoto Y, Ishitake T.

Int J Urol. 2014 Jul;21(7):658-63. doi: 10.1111/iju.12411.

15.

PSA bounce after permanent implant prostate brachytherapy may mimic a biochemical failure: a study of 295 patients with a minimum 3-year followup.

Toledano A, Chauveinc L, Flam T, Thiounn N, Solignac S, Timbert M, Rosenwald JC, Cosset JM.

Brachytherapy. 2006 Apr-Jun;5(2):122-6.

PMID:
16644467
16.

PSA kinetics after prostate brachytherapy: PSA bounce phenomenon and its implications for PSA doubling time.

Ciezki JP, Reddy CA, Garcia J, Angermeier K, Ulchaker J, Mahadevan A, Chehade N, Altman A, Klein EA.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):512-7.

PMID:
16213667
17.

Prostate specific antigen bounce is related to overall survival in prostate brachytherapy.

Hinnen KA, Monninkhof EM, Battermann JJ, van Roermund JG, Frank SJ, van Vulpen M.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):883-8. doi: 10.1016/j.ijrobp.2010.11.049.

18.

Prostate-specific antigen bounce after prostate seed implantation for localized prostate cancer: descriptions and implications.

Stock RG, Stone NN, Cesaretti JA.

Int J Radiat Oncol Biol Phys. 2003 Jun 1;56(2):448-53.

PMID:
12738319
19.

PSA bounce after prostate brachytherapy with or without neoadjuvant androgen deprivation.

McGrath SD, Antonucci JV, Fitch DL, Ghilezan M, Gustafson GS, Vicini FA, Martinez AA, Kestin LL.

Brachytherapy. 2010 Apr-Jun;9(2):137-44. doi: 10.1016/j.brachy.2009.07.005.

PMID:
19850537
20.

Prostate-specific antigen bounce after high-dose-rate prostate brachytherapy and hypofractionated external beam radiotherapy.

Patel N, Souhami L, Mansure JJ, Duclos M, Aprikian A, Faria S, David M, Cury FL.

Brachytherapy. 2014 Sep-Oct;13(5):450-5. doi: 10.1016/j.brachy.2014.05.005.

PMID:
25023396
Items per page

Supplemental Content

Support Center